Mechanism of Action of a Novel Latent Membrane Protein-1 Dominant Negative

This publication has 35 references indexed in Scilit:

• STATs in oncogenesis
  Oncogene, 2000
• Epstein–Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions
  Oncogene, 1998
• Epstein–Barr virus: LMP1 masquerades as an active receptor
  Current Biology, 1998
• Localization of the Major NF-κB-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs
  Journal of Biological Chemistry, 1997
• Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death
  Cell, 1996
• Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expression
  European Journal of Immunology, 1995
• The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
  Cell, 1993
• Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death
  Cell, 1991
• Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
  The Journal of Experimental Medicine, 1988
• An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
  Cell, 1985